Medical CannabisMedicines

Treating cases of epilepsy with the aid of medical cannabis and an fda approved epidiolex

Cannabis medical plant, or other refers to a marijuana plant, had been a controversial issue in the field of health because of its chemical substances that may be very helpful in treating various types of deceases. Food and Drug Administration had been very careful in approving the legal usage of the cannabis plant. Medical cannabis has two major chemical substances, the Tetrahydrocannabinol (THC) and the Cannabidiol (CBD). The THC is the chemical substance of the cannabis plant that causes a person to be “high” when they had used it. The CBD is the chemical substance of the cannabis plant that has a positive effect on the body of the user, such as reducing the seizure of a person with epilepsy.

Aside from the studies proving that medical cannabis is effective in reducing the pain of the effects of chemotherapy with the people who have cancer, it is also proved that medical cannabis can also be effective in treating and reducing the seizure of an epileptic person. Does cannabis really help an epileptic person to reduce their seizure? Yes! The chemical substance of cannabis plant, which is the CBD, it was studied in different laboratories and proven that it benefits the people to reduce their epileptic seizure. On July 25, 2018, the FDA already approved the Cannabidiol (CBD) formulation oil-based called “Epidiolex” as a treatment for reducing the seizure of an epileptic person. The epidiolex was formulated and studied by professional doctors before they tried it to cure the two rare severe types of epilepsy, the Lennox-Gastaut Syndrome and the Dravet Syndrome. Lennox-Gastaut Syndrome is epilepsy that begins in childhood. Seizures that begin in early childhood usually begin in the ages 3 to 5 years old. Dravet Syndrome is a fever-related seizure.

In the duration of studies, 689 people with epilepsy were treated using the epediolex. They also included in the study the 533 epileptic people that had a 6 months duration of treatment, and also, the people with epilepsy that was treated for more than a year are 391.

In Other programmes, the 161 people with the severe rare epilepsy the Lennox-Gastaut and Dravet Syndrome, for six months they were treated with epidiolex (CBD), and 109 was successfully treated while the 52 people were not fully treated but are able to reduce their seizure. The researchers are giving the right amount of dosage to their study participants (epileptic people) for them not to experience the severe side effects of epidiolex. A higher dosage of epidiolex can cause liver-related disease.

The epileptic people who are taking epidiolex suffer and feel the effect of the medicine because of its high dosage. Effects such as sleepiness, loss of appetite, fatigue, diarrhea, change in liver function, malaise, lack of energy, insomnia, and may suffer different types of infections.

Medical Cannabis has different side effects, and it varies depending on how the epileptic person uses it. In connection with the approval of the Food and Drug Administration in using medical cannabis for cases of epilepsy, there are some considerations and exceptions. There was a case in the United Kingdom that a British mother bought a cannabis oil for her son that has a severe type of epilepsy.

She was caught by United Kingdom’s official but later on, got an exception in the case. In the United States, the legalization of Medical Cannabis has been widely using in the country because it already gains approval from the Food and Drug Administration (FDA).

Sally Anderson

Sally is a Masters in Business Administration by education. After completing her post-graduation, Sally jumped the journalism bandwagon as a freelance journalist. Soon after that she landed a job of reporter and has been climbing the news industry ladder ever since to reach the post of editor.

Related Articles